PINCPremier, Inc.

Nasdaq premierinc.com


$ 21.18 $ 0.39 (1.88 %)    

Friday, 19-Apr-2024 15:59:52 EDT
QQQ $ 414.59 $ -8.76 (-2.07 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.36 (-0.87 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 21.18
$ 20.92
$ 21.18 x 200
$ 21.20 x 400
$ 20.90 - $ 21.23
$ 18.51 - $ 32.32
1,112,804
na
2.54B
$ 0.48
$ 15.20
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-06-2024 12-31-2023 10-Q
2 11-07-2023 09-30-2023 10-Q
3 08-22-2023 06-30-2023 10-K
4 05-03-2023 03-31-2023 10-Q
5 02-07-2023 12-31-2022 10-Q
6 11-01-2022 09-30-2022 10-Q
7 08-16-2022 06-30-2022 10-K
8 05-03-2022 03-31-2022 10-Q
9 02-01-2022 12-31-2021 10-Q
10 11-02-2021 09-30-2021 10-Q
11 08-17-2021 06-30-2021 10-K
12 05-04-2021 03-31-2021 10-Q
13 02-02-2021 12-31-2020 10-Q
14 11-03-2020 09-30-2020 10-Q
15 08-25-2020 06-30-2020 10-K
16 05-06-2020 03-31-2020 10-Q
17 02-05-2020 12-31-2019 10-Q
18 11-05-2019 09-30-2019 10-Q
19 08-23-2019 06-30-2019 10-K
20 05-07-2019 03-31-2019 10-Q
21 02-06-2019 12-31-2018 10-Q
22 11-07-2018 09-30-2018 10-Q
23 08-23-2018 06-30-2018 10-K
24 05-08-2018 03-31-2018 10-Q
25 02-06-2018 12-31-2017 10-Q
26 11-07-2017 09-30-2017 10-Q
27 08-23-2017 06-30-2017 10-K
28 05-10-2017 03-31-2017 10-Q
29 02-07-2017 12-31-2016 10-Q
30 11-08-2016 09-30-2016 10-Q
31 08-26-2016 06-30-2016 10-K
32 05-10-2016 03-31-2016 10-Q
33 02-09-2016 12-31-2015 10-Q
34 11-09-2015 09-30-2015 10-Q
35 08-26-2015 06-30-2015 10-K
36 05-12-2015 03-31-2015 10-Q
37 02-10-2015 12-31-2014 10-Q
38 11-12-2014 09-30-2014 10-Q
39 09-04-2014 06-30-2014 10-K
40 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 beebe-healthcare-selects-premier-as-supply-chain-operations-strategic-partner

https://premierinc.com/newsroom/press-releases/premier-inc-announces-strategic-supply-chain-partnership-with-beebe-healthcare 

 clinical-research-collaboration-between-premier-incs-pinc-ai-applied-sciences-and-mclaren-health-care-aims-to-advance-patient-outcomes---premier

https://premierinc.com/newsroom/press-releases/clinical-research-collaboration-between-premier-inc-s-pinc-ai-applied-sciences-a...

 leerink-partners-initiates-coverage-on-premier-with-market-perform-rating-announces-price-target-of-225

Leerink Partners analyst Michael Cherny initiates coverage on Premier (NASDAQ:PINC) with a Market Perform rating and announc...

 us-federal-trade-commission-investigates-drug-shortages-amid-allegations-of-market-manipulation

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scru...

 premier-incs-pinc-ai-applied-sciences-and-datavant-collaborate-to-enable-next-generation-clinical-trials

Builds on existing partnership by further leveraging the combined power of real-world data, real-world evidence and privacy-pre...

 healthcare-purchasing-network-premier-launches-1b-share-buyback-program-concludes-strategic-review-process-after-q2-performance

Premier charts a strategic path with a $1.0 billion share repurchase plan through June 2025. Q2 2024 earnings: EPS $0.60, sales...

 premier-q2-2024-adj-eps-060-beats-057-estimate-sales-33475m-miss-34150m-estimate

Premier (NASDAQ:PINC) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.57 by 5.26...

 langaware-forges-transformative-collaboration-with-premier-incs-pinc-ai-applied-sciences-to-revolutionize-healthcare

Real-world data to support early patient identification for patients with neurodegenerative and behavioral health diseases.NEW ...

 premiers-pinc-ai-applied-sciences-and-tfs-healthscience-to-partner-to-improve-patient-outcomes-and-reduce-health-disparities-combine-tfs-capabilities-systems-and-clinical-development-expertise-with-pas-ai-enabled-technology-and-healthcare-database

Leveraging comprehensive real-world data (RWD) and AI-enabled tools from PAS, TFS will gain enhanced capabilities to assess sit...

 wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

 tufts-medicine-selects-premier-inc-as-strategic-partner-to-achieve-supply-chain-excellence-the-financial-terms-of-the-partnership-were-not-disclosed

Extends group purchasing organization (GPO) contract for 10 years.Expands services to include co-management of supply chain ope...

 jp-morgan-maintains-neutral-on-premier-lowers-price-target-to-21

JP Morgan analyst Anne Samuel maintains Premier (NASDAQ:PINC) with a Neutral and lowers the price target from $26 to $21.

 expert-ratings-for-premier
Expert Ratings for Premier
11/09/2023 21:00:18

 benchmark-maintains-buy-on-premier-lowers-price-target-to-30

Benchmark analyst Bill Sutherland maintains Premier (NASDAQ:PINC) with a Buy and lowers the price target from $32 to $30.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION